Company
Headquarters: Heidenheim, Germany
Employees: 10,622
CEO: Ms. Britta Fuenfstueck
€824.0 Million
EUR as of Jan. 1, 2026
US$967.7 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Paul Hartmann AG manufactures and sells medical and care products in Europe, Africa, Asia, and Oceania. It offers disinfectant products for hands, surface, and instruments; cleaning, skin care, and skin antisepsis products, as well as Sterillium, a hand disinfectant; incontinence management products; and personal healthcare products, such as diagnostic devices and first aid products. The company also provides single-use and pre-surgical products, disposable surgical gloves, clothing and gowns, and disposable drapes for use in operating theatres, treatment rooms, and wards; and wound management solutions, including traditional compresses, bandages, hydro therapy products. In addition, it markets body care, dietary supplements, and herbal medicinal products; and distributes private-label products, such as cotton/cosmetic, medical, and baby and home care products. The company was founded in 1818 and is based in Heidenheim, Germany.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | €2.44 B |
| EBITDA | €246.0 M |
| Gross Profit TTM | €1.42 B |
| Profit Margin | 3.33% |
| Operating Margin | 3.66% |
| Quarterly Revenue Growth | 1.60% |
Paul Hartmann AG has the following listings and related stock indices.
Stock: FSX: PHH2 wb_incandescent